Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
01/2009
01/13/2009US7476525 Modified pyrroloquinoline quinone (PQQ) dependent glucose dehydrogenase with superior substrate specificity and stability
01/13/2009US7476524 Comprises nucleotide sequences coding prostaglandin h synthase for treatment of inflammation; antiinflammatory agents; cytoprotective agents
01/13/2009US7476520 Employed in methods to identify nucleic acid characteristic of family-specific beta-lactamase enzymes in clinical isolates of Gram- negative bacteria
01/13/2009US7476519 Screening chemical libraries to identify compounds using expressed RNA; high throughput assay
01/13/2009US7476518 Nucleic acids encoding fluorescent proteins and methods of using the same
01/13/2009US7476515 Affinity trap reactor and single-step process for purifying angiostatin-like fragment from human plasma using the same
01/13/2009US7476514 Method for monitoring the immune response and predicting clinical outcomes in transplant recipients
01/13/2009US7476512 Methods of identifying dermal papilla cells
01/13/2009US7476507 Infecting cells (serum free media), monitoring viability using flow cytometry open reading frame expression with flourescent antibody cell sorting; Postweaning multisystemic wasting syndrome; rapid, high yield
01/13/2009US7476506 Use of NRG4, or inhibitors thereof, in the treatment of colon and pancreatic cancers
01/13/2009US7476505 Devices for generating detectable polymers
01/13/2009US7476504 Use of reversible extension terminator in nucleic acid sequencing
01/13/2009US7476503 high-throughput and low-cost single-molecular analysis; optically capturing analyte within an optical confinement created by providing an array of waveguides having a fill fraction greater than about 0.0001; and illuminating waveguide suspected to contain analyte with incident light beam
01/13/2009US7476502 improved sensitivity, reproducibility and/or lower detection limits; Nucleic acid analytes can be co-amplified with known amounts of corresponding competitive templates; non-nucleic acid analytes can be coupled to nucleic acid tags and tags can be co-amplified with known amounts of competitive templates
01/13/2009US7476501 Methods and device for DNA sequencing using surface enhanced raman scattering (SERS)
01/13/2009US7476500 activity of a biological cleavage enzyme, such as a site-specific recombinase, a homing endonuclease, or an intein, is linked to cell viability and therefore can be selected
01/13/2009US7476499 Using virally infected mammalian cells as models for screening viricidal agents; drug screening
01/13/2009US7476498 Peptides derived from capsid antigens of the Epstein-Barr virus and the use thereof
01/13/2009US7476497 Systems and methods for characterizing kidney diseases
01/13/2009US7476496 Method for preparing an extracellular matrix and its use for tumor cell culture
01/13/2009US7476391 Attenuated pasteurella for use as tool in developing bactericidal agents; immunotherapy
01/13/2009US7476390 Polypeptides and polynucleotides useful in methods of inducing immune response against flaviviruses, including dengue viruses
01/13/2009US7476389 Papillomavirus vaccines
01/13/2009US7476384 Death domain containing receptor 4 antibody and methods
01/13/2009US7476382 Reovirus for the treatment of neoplasia
01/13/2009CA2463940C Automated system and method for processing specimens to extract samples for both liquid-based and slide-based testing
01/13/2009CA2463673C Filtration system and method for obtaining a cytology layer
01/13/2009CA2461734C Container uncapping apparatus and method
01/13/2009CA2446982C Synthesis and evaluation of new cyanine dyes as minor groove of [poly(da-dt)]2 binders
01/13/2009CA2374729C Novel organic anion transport proteins
01/13/2009CA2363853C Laser diode-excited biological particle detection system
01/13/2009CA2296044C Oligonucleotide primers for efficient multiplex detection of hepatitis c virus (hcv) and human immunodeficiency virus (hiv) and methods of use thereof
01/13/2009CA2287524C Dna probes, method and kit for identifying antibiotic-resistant strains of bacteria
01/13/2009CA2286845C Equipment, kit and method for microbiological diagnosis
01/13/2009CA2273078C Use of nucleic acids bound to carrier macromolecules
01/13/2009CA2258803C Biochemical analysis of antioxidant function
01/13/2009CA2220085C Surface colony counting device and method of use
01/13/2009CA2185128C Method and device for detection of specific target cells in specialized or mixed cell populations and solutions containing mixed cell populations
01/13/2009CA2161771C Methods of identifying potentially therapeutically effective agents and cell strains for use therein
01/09/2009CA2593623A1 The applications of kidney secreted bone growth factor and pharmaceutical use of flavonol and flavonol glycosides for stimulating the secretion of kidney secreted bone growth factor
01/08/2009WO2009006598A1 Multiplexed assembly of high fidelity dna
01/08/2009WO2009006584A2 Methods and compositions for identifying cellular rna transcripts
01/08/2009WO2009006583A1 Treatment of cardiovascular disease with salicylates
01/08/2009WO2009006543A1 Methods for evaluating the methylation status of a polynucleotide
01/08/2009WO2009006450A1 Bacteria-mediated gene modulation via microrna machinery
01/08/2009WO2009006446A2 Methods for cloning small rna species
01/08/2009WO2009006445A2 Systems and methods for electronic detection with nanofets
01/08/2009WO2009006438A2 Copy dna and sense rna
01/08/2009WO2009006429A1 Host cells and methods for producing 3-methyl-2-buten-1-ol, 3-methyl-3-buten-1-ol, and 3-methyl-butan-1-ol
01/08/2009WO2009006417A2 Methods for extraction and purification of components of biological samples
01/08/2009WO2009006382A1 Detection of glycopeptides and glycoproteins for medical diagnostics
01/08/2009WO2009006140A1 Use of mdck cells in the evaluation of cholesterol modulators
01/08/2009WO2009005869A2 Biological detection system and method
01/08/2009WO2009005861A2 Method and device for detection of erythromycin-induced clindamycin resistance
01/08/2009WO2009005688A2 Activating mutations in notch-1
01/08/2009WO2009005631A2 Hybrid solid supports useful for oligonucleotide production
01/08/2009WO2009005615A1 Methods and compositions for identifying agents that inhibit an ns4b-mediated neoplastic cellular phenotype of hcv infected cells
01/08/2009WO2009005552A2 Methods and compositions for multivalent binding and methods for manufacture of rapid diagnostic tests
01/08/2009WO2009005542A2 Detection of bioagents using a shear horizontal surface acoustic wave biosensor
01/08/2009WO2009005536A2 Methods of capturing bacterial whole cells and methods of analyzing samples for bacteria
01/08/2009WO2009005178A1 Microarrays for detection and identification of microorganisms associated with periodontal diseases and method for diagnosis of infectious oral diseases using the microarray
01/08/2009WO2009005155A1 Method for maintaining proliferation/differentiation ability of mesenchymal stem cell
01/08/2009WO2009005142A1 Method for diagnosis of malignancy of gastrointestinal stromal tumor whose primary lesion is in stomach
01/08/2009WO2009005095A1 Treatment of influenza
01/08/2009WO2009005001A1 Apparatus for detecting/identifying gene, apparatus for gene reaction and incubator
01/08/2009WO2009004630A1 Chimeric primers for improved nucleic acid amplification reactions
01/08/2009WO2009004443A2 Compositions for the detection of gene expression in diabetic microangiopathy
01/08/2009WO2009004340A2 Identification of ectopic pregnancies
01/08/2009WO2009004335A1 High multiplex nucleic acid amplification
01/08/2009WO2009004247A2 Tace inhibitors in the treatment of acne
01/08/2009WO2009004104A1 Use of a polymorphism in the card8 gen for prognosis of rheumatoid arthritis
01/08/2009WO2009004102A2 Method for the internalization of non-invasive bacteria in eukaryote cells
01/08/2009WO2009004068A2 Androgen-dependent 1-f-aromatase reporter gene
01/08/2009WO2009004065A2 Providing improved immunoglobulin sequences by mutating cdr and/or fr positions
01/08/2009WO2009004056A1 Method for the multiplex serological diagnosis in vitro of spirochete infections
01/08/2009WO2009003951A1 Nanoassembled complexes of nucleic acids, avidin and polymers, use and preparation thereof
01/08/2009WO2009003905A2 Prognostic method for the determination of the suitability of biopharmaceutical treatment
01/08/2009WO2009003706A2 Methods, kits, and compounds for determining responsiveness to treatment of a pathological disorder by epothilones
01/08/2009WO2009003495A1 Method and a kit for identifying a human who has the predisposition for increased consumption of carbohydrates and method for managing the named human's dietary intake of nutritional energy
01/08/2009WO2009003291A1 Therapeutics and diagnostics for group a streptococci
01/08/2009WO2009003274A1 Susceptibility gene for inflammatory bowel disease
01/08/2009WO2009003273A1 Assessing tissue rejection
01/08/2009WO2009003222A1 Methods for degrading toxic compounds
01/08/2009WO2009003208A1 Method for identifying and quantifying organic and biochemical substances
01/08/2009WO2008144700A3 Simian t-cell lymphotropic virus type 3 west african subtype d
01/08/2009WO2008143903A3 Methods of screening nucleic acids for single nucleotide variations
01/08/2009WO2008140651A3 Self-assembled polyhedra
01/08/2009WO2008140620A3 Ultra sensitive biomolecule detection using double stranded dna co-loaded gold nanoparticles and co-immobilized capture molecules
01/08/2009WO2008140608A3 Methods and devices for detecting methicillin resistant staphylococcus aureus
01/08/2009WO2008138928A3 Diagnostic of immune graft tolerance
01/08/2009WO2008138619A3 New ttv sequences for diagnosis, prevention and treatment of childhood leukaemia
01/08/2009WO2008138341A3 Methods for detection of 'pontiac' subgroups of legionella pneumophila serogroup 1
01/08/2009WO2008137636A3 Compositions and methods for identifying and treating subjects at risk of developing type 2 diabetes
01/08/2009WO2008135512A3 Dna amplification method
01/08/2009WO2008135508A3 Human diabetes susceptibility eefsec gene
01/08/2009WO2008133729A3 Sequential analysis of biological samples with intermediate bleaching of fluorescence detector
01/08/2009WO2008131039A3 Cardibioindex/cardibioscore and utility of salivary proteome in cardiovascular diagnostics
01/08/2009WO2008127921A3 Primer and probe sequences for detecting chlamydia trachomatis
01/08/2009WO2008126107A3 Genetic variants associated with periodic limb movements and restless legs syndrome
01/08/2009WO2008100344A3 Fluorescent methods and materials for directed biomarker signal amplification